Number of the records: 1
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
Title Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer Author info Ray-Coquard I., Minárik T. ... [et al.] Co-authors Ray-Coquard I.
Minárik Tomáš
Corporation Redakcia Onkológia
Note Int J. Cancer. 2019 Aug 5 Sign. C 3069 Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2019 . - Roč. 14, č. 5 (2019), s. 372 MeSH Subject nádory vaječníkov : farmakoterapia
farmakoterapia kombinovaná
proteíntyrozínkinázy : antagonisty a inhibítory
karboplatina
paklitaxel
skúšanie klinické, fáza III, ako téma
výsledok liečby
Subj. Headings nintedanib * štúdia AGO-OVAR 12 Language English Country Slovak Republic Document kind Rozpis článkov z periodík Database ARTICLES 
article
Number of the records: 1